IMCR · Immunocore Holdings plc · Held by Funds
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of IMCR by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 1.05% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 0.05% | 26,042 |
| Index ETFs | 1.00% | 516,877 |
| Active ETFs | 0.06% | 30,849 |
| Active funds | 12.40% | 6,407,799 |
| Unclassified | 0.03% | 13,778 |
| All registered funds | 13.54% | 6,995,345 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding IMCR
57 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth Fund | POAGX | 1,111,200 | $37,569,672 | 0.51% | Long | 2026-07-31 | |
| Fidelity Growth Company Fund | — | 635,923 | $23,096,723 | 0.02% | Long | 2026-08-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 645,268 | $20,487,259 | 0.17% | Long | 2026-06-30 | |
| Select Health Care Portfolio | — | 500,000 | $18,160,000 | 0.27% | Long | 2026-08-31 | |
| BlackRock Health Sciences Term Trust | BMEZ | 359,126 | $11,402,251 | 1.06% | Long | 2026-06-30 | |
| MFS New Discovery Fund | — | 304,295 | $11,051,994 | 0.52% | Long | 2026-08-31 | |
| Select Biotechnology Portfolio | FBIOX | 287,200 | $10,431,104 | 0.17% | Long | 2026-08-31 | |
| iShares Biotechnology ETF | IBB | 299,288 | $9,502,394 | 0.10% | Long | 2026-06-30 | |
| Fidelity Advisor Health Care Fund | — | 260,000 | $8,790,600 | 0.28% | Long | 2026-07-31 | |
| SmallCap Fund | — | 217,900 | $7,367,199 | 0.35% | Long | 2026-07-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 188,691 | $6,853,257 | 0.11% | Long | 2026-08-31 | |
| Fidelity Growth Company K6 Fund | FGKFX | 164,897 | $5,989,059 | 0.02% | Long | 2026-08-31 | |
| Old Westbury Small & Mid Cap Strategies Fund | OWSMX | 159,882 | $5,405,610 | 0.06% | Long | 2026-07-31 | |
| Fidelity Capital Appreciation Fund | — | 158,900 | $5,372,409 | 0.07% | Long | 2026-07-31 | |
| Fidelity Series Growth Company Fund | FCGSX | 141,670 | $5,145,454 | 0.02% | Long | 2026-08-31 | |
| THE HARTFORD HEALTHCARE FUND | — | 108,668 | $3,674,065 | 0.48% | Long | 2026-07-31 | |
| MFS New Discovery Series | — | 102,016 | $3,239,008 | 0.40% | Long | 2026-06-30 | |
| VIP Health Care Portfolio | — | 84,000 | $2,667,000 | 0.23% | Long | 2026-06-30 | |
| ALPS Medical Breakthroughs ETF | SBIO | 62,739 | $2,278,680 | 0.95% | Long | 2026-08-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | SPDW | 63,742 | $2,023,809 | 0.01% | Long | 2026-06-30 | |
| Tema Oncology ETF | CANC | 44,900 | $1,630,768 | 0.77% | Long | 2026-08-31 | |
| Virtus Biotech Etf | BBP | 46,863 | $1,584,438 | 1.61% | Long | 2026-07-31 | |
| T. Rowe Price Health Sciences Portfolio | — | 43,439 | $1,379,188 | 0.18% | Long | 2026-06-30 | |
| VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND | — | 37,273 | $1,260,200 | 0.22% | Long | 2026-07-31 | |
| Steward Values Enhanced International Fund | — | 35,726 | $1,207,896 | 0.36% | Long | 2026-07-31 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | GWX | 34,287 | $1,088,612 | 0.13% | Long | 2026-06-30 | |
| Large-Cap Growth Portfolio | — | 25,652 | $814,451 | 0.06% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index ETF | ONEQ | 19,914 | $723,276 | 0.01% | Long | 2026-08-31 | |
| SmallCap Account | — | 19,700 | $625,475 | 0.32% | Long | 2026-06-30 | |
| iShares International Small-Cap Equity Factor ETF | ISCF | 17,076 | $577,340 | 0.09% | Long | 2026-07-31 | |
| Nationwide International Small Cap Fund | — | 16,155 | $546,201 | 0.19% | Long | 2026-07-31 | |
| BlackRock Health Sciences Trust | BME | 16,565 | $525,939 | 0.09% | Long | 2026-06-30 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 14,378 | $522,209 | 0.00% | Long | 2026-08-31 | |
| Harbor International Core Fund | — | 14,632 | $494,708 | 0.02% | Long | 2026-07-31 | |
| HARTFORD HEALTHCARE HLS FUND | — | 15,428 | $467,314 | 0.42% | Long | 2026-09-30 | |
| Health Sciences Trust | — | 13,301 | $422,307 | 0.17% | Long | 2026-06-30 | |
| Catholic Values Equity Fund | — | 10,108 | $367,123 | 0.08% | Long | 2026-08-31 | |
| EQ/T.Rowe Price Health Sciences Portfolio | — | 11,527 | $365,982 | 0.21% | Long | 2026-06-30 | |
| Health Sciences Portfolio | — | 11,435 | $363,061 | 0.10% | Long | 2026-06-30 | |
| Blackstone Alternative Multi-Strategy Fund | — | 10,800 | $327,132 | 0.01% | Long | 2026-09-30 | |
| Amplify Treatments, Testing and Advancements ETF | — | 9,166 | $310,636 | 3.36% | Long | 2024-06-30 | |
| International Opportunities Fund | VIOPX | 7,402 | $268,841 | 0.09% | Long | 2026-08-31 | |
| ActivePassive International Equity ETF | APIE | 5,043 | $183,162 | 0.02% | Long | 2026-08-31 | |
| VIP Dynamic Capital Appreciation Portfolio | — | 5,700 | $180,975 | 0.06% | Long | 2026-06-30 | |
| Range Cancer Therapeutics ETF | CNCR | 4,770 | $140,095 | 1.57% | Long | 2025-02-28 | |
| AVIP Fidelity Institutional AM Equity Growth Portfolio | — | 4,330 | $137,478 | 0.06% | Long | 2026-06-30 | |
| Invesco Nasdaq Biotechnology ETF | IBBQ | 2,769 | $100,570 | 0.10% | Long | 2026-08-31 | |
| Multi-Manager U.S. Small Cap Equity Fund | MMSMX | 3,458 | $96,513 | 0.03% | Long | 2026-04-30 | |
| Guardian Large Cap Fundamental Growth VIP Fund | — | 2,714 | $86,170 | 0.05% | Long | 2026-06-30 | |
| Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | PDN | 2,035 | $68,803 | 0.02% | Long | 2026-07-31 |